Chester County News and Community Website
BERWYN, PA — Panavance Therapeutics Inc. announced the U.S. Food and Drug Administration (FDA) recently granted Orphan Drug Designation to GP-2250 for the treatment of all forms of pancreatic cancer.
Panavance Therapeutics Announces Orphan Drug Designation for GP-2250 Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently granted its request for …
European Medicines Agency Grants Marinus Pharmaceuticals Accelerated Assessment of Ganaxolone for Treatment of CDKL5 Deficiency Disorder Read More RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) this week announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 …
Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results Read More
HORSHAM, PA — The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with …
Janssen Announces FDA Approval of DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of …
FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Abecma (idecabtagene vicleucel), a cell-based gene therapy to treat adult patients with multiple myeloma who have not responded to, or …
FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma Read More
MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from …
European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate Read More